Showing 361 - 380 results of 71,565 for search '(( 50 ((nn decrease) OR (a decrease)) ) OR ( 5 ((nn decrease) OR (a decrease)) ))', query time: 0.69s Refine Results
  1. 361

    S5 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  2. 362

    Expanding Three-Coordinate Gold(I) Anticancer Agent Chemical Space by Charles E. Greif (21728091)

    Published 2025
    “…The complexes demonstrated submicromolar cytotoxic activity against human breast cancer cells MDA-MB-231 or MDA-MB-468 with IC<sub>50</sub>’s in the range of 0.4–5.0 μM. Complex <b>2e</b> shows high potency in vitro and decreases 3D-breast cancer mammosphere viability. …”
  3. 363
  4. 364
  5. 365

    Inhibiting Gamma-secretase activity without interfering in Notch signaling: Decreasing the inflammatory response in patients with cutaneous leishmaniasis by Lucas Carvalho (3093042)

    Published 2020
    “…Statistical analyses were performed using the Wilcoxon test *P<0.05 and **P<0.01.</p><p><b>Figure 5 - Selective gamma-secretase inhibitor (JLK6) decreases pro-inflammatory cytokine production from CL patients.…”
  6. 366
  7. 367
  8. 368
  9. 369
  10. 370

    Fig 2 - by Muhammad Imran Nisar (10226212)

    Published 2022
    Subjects:
  11. 371
  12. 372
  13. 373
  14. 374
  15. 375
  16. 376

    Skp2 inhibitor SKPin C1 decreased viability and proliferation of multiple myeloma cells and induced apoptosis by Ying Yang (24175)

    Published 2019
    “…The viability of U266 and RPMI 8226 cells was significantly inhibited by 10 μM SKPin C1 and the inhibitory effect was enhanced with increasing doses of SKPin C1. In contrast, 50 μM SKPin C1 only marginally decreased viability of normal B lymphocytes in 12 h. …”
  17. 377
  18. 378
  19. 379
  20. 380